almagate has been researched along with Central Serous Retinopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arevalo, JF; Espinoza, JV | 1 |
1 other study(ies) available for almagate and Central Serous Retinopathy
Article | Year |
---|---|
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Central Serous Chorioretinopathy; Chronic Disease; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2011 |